Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer.
about
Induction of apoptosis and proliferation inhibition of hepatocellular carcinoma by 6-chloro-2-methoxy-N-(phenylmethyl)-9-acridinamine (BA): in vitro and vivo studies.Eribulin for heavily pre-treated metastatic breast cancer patientsExamination of the clinical efficacy of eribulin and trastuzumab in HER2-positive recurrent breast cancer.Malignant Adenomyoepithelioma of the Breast and Responsiveness to Eribulin.
P2860
Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Eribulin mesylate as a microtu ...... with metastatic breast cancer.
@ast
Eribulin mesylate as a microtu ...... with metastatic breast cancer.
@en
type
label
Eribulin mesylate as a microtu ...... with metastatic breast cancer.
@ast
Eribulin mesylate as a microtu ...... with metastatic breast cancer.
@en
prefLabel
Eribulin mesylate as a microtu ...... with metastatic breast cancer.
@ast
Eribulin mesylate as a microtu ...... with metastatic breast cancer.
@en
P2093
P2860
P356
P1476
Eribulin mesylate as a microtu ...... with metastatic breast cancer.
@en
P2093
Eva Muñoz-Couselo
Javier Cortés
José Pérez-García
P2860
P304
P356
10.2147/OTT.S16392
P407
P577
2011-11-14T00:00:00Z